JANIE WALZ: Open Payments
NPI 1285331967 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,358 in 85 payments from 14 companies in 2025. Trend: 2023 $1,434 · 2024 $2,238 · 2025 $3,358
Food & beverage: $3,358
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $622 |
| Janssen Pharmaceuticals, Inc | 12 | $474 |
| ABBVIE INC. | 10 | $442 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $394 |
| E.R. Squibb & Sons, L.L.C. | 10 | $269 |
| Otsuka America Pharmaceutical, Inc. | 8 | $229 |
| Axsome Therapeutics, Inc. | 3 | $209 |
| Alkermes, Inc. | 4 | $150 |
| Vanda Pharmaceuticals Inc. | 7 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $124 |
Products named: UZEDY, VRAYLAR, CAPLYTA, COBENFY, INVEGA SUSTENNA, SPRAVATO, Auvelity, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
